← Back to archive day

Causal Diffusion Models for Counterfactual Outcome Distributions in Longitudinal Data

Farbod Alinezhad, Jianfei Cao, Gary J. Young, Brady Post

36

Recommendation Score

breakthrough🔴 AdvancedMultimodalDiffusion ModelsMethodUseful for both

Research context

Primary field

Multimodal

Systems that connect text, vision, audio, and other modalities.

Topics

Diffusion Models

Paper type

Method

Best for

Useful for both

arXiv categories

cs.LG

Why It Matters

CDM is the first diffusion model for counterfactual longitudinal outcomes, enabling accurate, uncertainty-quantified treatment effect predictions—vital for clinical decision systems and causal AI in healthcare.

Abstract

Predicting counterfactual outcomes in longitudinal data, where sequential treatment decisions heavily depend on evolving patient states, is critical yet notoriously challenging due to complex time-dependent confounding and inadequate uncertainty quantification in existing methods. We introduce the Causal Diffusion Model (CDM), the first denoising diffusion probabilistic approach explicitly designed to generate full probabilistic distributions of counterfactual outcomes under sequential interventions. CDM employs a novel residual denoising architecture with relational self-attention, capturing intricate temporal dependencies and multimodal outcome trajectories without requiring explicit adjustments (e.g., inverse-probability weighting or adversarial balancing) for confounding. In rigorous evaluation on a pharmacokinetic-pharmacodynamic tumor-growth simulator widely adopted in prior work, CDM consistently outperforms state-of-the-art longitudinal causal inference methods, achieving a 15-30% relative improvement in distributional accuracy (1-Wasserstein distance) while maintaining competitive or superior point-estimate accuracy (RMSE) under high-confounding regimes. By unifying uncertainty quantification and robust counterfactual prediction in complex, sequentially confounded settings, without tailored deconfounding, CDM offers a flexible, high-impact tool for decision support in medicine, policy evaluation, and other longitudinal domains.

Published April 14, 2026
© 2026 A2A.pub — AI to Action. From papers to practice, daily.
Summaries are AI-assistedPrivacyTerms